Ghionul Ibram

569 total citations
8 papers, 318 citations indexed

About

Ghionul Ibram is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Ghionul Ibram has authored 8 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cardiology and Cardiovascular Medicine, 3 papers in Endocrinology, Diabetes and Metabolism and 2 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Ghionul Ibram's work include Heart Failure Treatment and Management (4 papers), Renin-Angiotensin System Studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Ghionul Ibram is often cited by papers focused on Heart Failure Treatment and Management (4 papers), Renin-Angiotensin System Studies (3 papers) and Cardiovascular Function and Risk Factors (3 papers). Ghionul Ibram collaborates with scholars based in United States, Switzerland and Germany. Ghionul Ibram's co-authors include Yağız Üresin, Charles Kilo, Addison A. Taylor, Diethelm Tschöpe, Hui Fang, Massimo Santonastaso, Andrew Satlin, Burkert Pieske, Rolf Wachter and Sanjiv J. Shah and has published in prestigious journals such as Circulation, European Heart Journal and Schizophrenia Research.

In The Last Decade

Ghionul Ibram

8 papers receiving 304 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ghionul Ibram United States 7 264 163 21 20 19 8 318
G. L. Schwartz United States 12 197 0.7× 123 0.8× 27 1.3× 23 1.1× 8 0.4× 16 303
Marina Crivaro Italy 11 343 1.3× 77 0.5× 28 1.3× 19 0.9× 7 0.4× 17 392
Agnes D. Mejia Philippines 5 281 1.1× 109 0.7× 19 0.9× 11 0.6× 17 0.9× 8 383
Valéria Nasser Figueiredo Brazil 10 280 1.1× 134 0.8× 27 1.3× 18 0.9× 10 0.5× 40 436
S. Colman Australia 8 204 0.8× 110 0.7× 38 1.8× 21 1.1× 5 0.3× 11 340
B Bouhanick France 9 173 0.7× 122 0.7× 28 1.3× 28 1.4× 7 0.4× 22 307
Paolo Poisa Italy 4 322 1.2× 59 0.4× 10 0.5× 46 2.3× 7 0.4× 4 368
Pieralberto Visentin Italy 10 386 1.5× 248 1.5× 40 1.9× 43 2.1× 11 0.6× 15 563
A Circo Italy 6 337 1.3× 56 0.3× 23 1.1× 16 0.8× 9 0.5× 18 408

Countries citing papers authored by Ghionul Ibram

Since Specialization
Citations

This map shows the geographic impact of Ghionul Ibram's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ghionul Ibram with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ghionul Ibram more than expected).

Fields of papers citing papers by Ghionul Ibram

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ghionul Ibram. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ghionul Ibram. The network helps show where Ghionul Ibram may publish in the future.

Co-authorship network of co-authors of Ghionul Ibram

This figure shows the co-authorship network connecting the top 25 collaborators of Ghionul Ibram. A scholar is included among the top collaborators of Ghionul Ibram based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ghionul Ibram. Ghionul Ibram is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Shah, Amil M., Brian Claggett, Narayana Prasad, et al.. (2022). Impact of Sacubitril/Valsartan Compared With Ramipril on Cardiac Structure and Function After Acute Myocardial Infarction: The PARADISE-MI Echocardiographic Substudy. Circulation. 146(14). 1067–1081. 32 indexed citations
2.
Wachter, Rolf, Burkert Pieske, Abigail S. Baldridge, et al.. (2022). Reduction in heart failure hospitalizations by sacubitril/valsartan; a post-hoc analysis of the PARALLAX trial. European Heart Journal. 43(Supplement_2). 2 indexed citations
3.
Shah, Sanjiv J., Martín Cowie, Rolf Wachter, et al.. (2021). Baseline characteristics of patients in the PARALLAX trial: insights into quality of life and exercise capacity in heart failure with preserved ejection fraction. European Journal of Heart Failure. 23(9). 1541–1551. 13 indexed citations
4.
Wachter, Rolf, Sanjiv J. Shah, Martín Cowie, et al.. (2020). Angiotensin Receptor Neprilysin Inhibition versus Individualized RAAS Blockade: Design and Rationale of the PARALLAX Trial. ESC Heart Failure. 7(3). 856–864. 29 indexed citations
5.
Bao, Yuanyuan, Ghionul Ibram, William S. Blaner, et al.. (2012). Low maternal retinol as a risk factor for schizophrenia in adult offspring. Schizophrenia Research. 137(1-3). 159–165. 35 indexed citations
7.
Blumenstein, M, Jerzy Romaszko, Karl Andersen, et al.. (2009). Antihypertensive efficacy and tolerability of aliskiren/hydrochlorothiazide (HCT) single-pill combinations in patients who are non-responsive to HCT 25 mg alone. Current Medical Research and Opinion. 25(4). 903–910. 26 indexed citations
8.
Üresin, Yağız, Addison A. Taylor, Charles Kilo, et al.. (2007). Efficacy and safety of the direct renin inhibitor aliskiren and ramipril alone or in combination in patients with diabetes and hypertension. Journal of the Renin-Angiotensin-Aldosterone System. 8(4). 190–200. 173 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026